Universitätsklinikum Augsburg

Hospital


Location: Augsburg, Germany (DE) DE

ISNI: -


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Comparative real-world effectiveness and persistence of vedolizumab versus anti-TNF therapy in biologic-naive patients with Crohn's Disease with Propensity Score adjustment: Maintenance phase results at week-52 from the prospective VEDOIBD study (2022) Di Giuseppe R, Plachta-Danielzik S, Bokemeyer B, Efken P, Mohl W, Hoffstadt M, Krause T, et al. Conference contribution Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies? (2022) Jonigk D, Werlein C, Acker T, Aepfelbacher M, Amann KU, Baretton G, Barth P, et al. Journal article, Review article IgG4-related pseudotumours: a series of 12 cases and a review of the literature (2022) Maccagno A, Grosser B, Füzesi L, Konukiewitz B, Vlasenko D, Weckermann D, Raab S, et al. Journal article Risk for Pelvic Metastasis and Role of Pelvic Lymphadenectomy in Node-Positive Vulvar Cancer-Results from the AGO-VOP.2 QS Vulva Study (2022) Woelber L, Hampl M, Eulenburg CZ, Prieske K, Hambrecht J, Fuerst S, Klapdor R, et al. Journal article Quantitative analysis of submucosal excision depth in endoscopic resection for early Barrett's cancer (2021) Krause J, Roesch T, Steurer S, Clauditz T, Sehner S, Schumacher U, Neuhaus H, et al. Journal article Influence of Turkish origin on hematology reference intervals in the German population (2021) Mayr FX, Bertram A, Cario H, Frühwald MC, Groß HJ, Groening A, Grützner S, et al. Journal article Characteristics and Outcome of Patients with Acute Myeloid Leukemia and Trisomy 4 (2021) Kayser S, Martinez-Cuadron D, Hanoun M, Stoelzel F, Gil C, Reinhardt HC, Aguiar E, et al. Conference contribution Allogeneic Hematopoietic Cell Transplantation in Patients <= 60 Years with Intermediate-Risk Acute Myeloid Leukemia in First Remission - Results of the Randomized Etal-1 Trial- (2021) Bornhaeuser M, Schliemann C, Schetelig J, Rollig C, Kramer M, Glass B, Platzbecker U, et al. Conference contribution Final Induction Therapy Results of an Open Label Phase II Study Using Inotuzumab Ozogamicin for Induction Therapy, Followed By a Conventional Chemotherapy Based Consolidation and Maintenance Therapy in Patients Aged 56 Years and Older with Acute BLymphoblastic Leukemia (INITIAL-1 trial) (2021) Stelljes M, Alakel N, Waesch R, Scholl S, Nachtkamp K, Rank A, Haenel M, et al. Conference contribution Emergency Use of Convalescent Plasma: Perception of the Regulatory Framework from a Clinical Perspective (2021) Mohnle P, Humpe A, Boeck M, Gruetzner S, Hackstein H, Offner R, Hildebrandt M Journal article, Review article